Up To 50 SAR OFF Your First Order Use Code : APP50 | Get Free Delivery With No Minimum Order

Frequently bought together
ETRIVEX 0.05% SHAMPOO
- Sku : I-013137
Key features
ETRIVEX 0.05% Shampoo contains clobetasol propionate 0.05% and is formulated as a prescription topical shampoo. It acts as a very potent topical corticosteroid, suppressing local inflammation and immune-mediated skin cell proliferation. It is indicated for the topical treatment of moderate scalp psoriasis in adults. Available as a 125 ml prescription shampoo.- Brand: ETRIVEX
- Active Ingredient: CLOBETASOL PROPIONATE 0.05%
- Strength: 0.05%
- Dosage Form: Shampoo
- Pack Size: 125 ml
- Route: Topical
- Prescription Status: Prescription
- Therapeutic Class: Dermatological
- Pharmacological Group: Corticosteroids (Plain)
- Drug Class: Very Potent Topical Corticosteroid (Class I)
- Manufacturer: GALDERMA
- Country of Origin: France
- SFDA Registration No.: 13-274-10
- Shelf Life: 36 months
- Storage: store below 30°c
- Skin Condition: Psoriasis
- Steroid Potency: Very Potent
Frequently bought together
Indications
Approved Uses
Topical treatment of moderate scalp psoriasis in adults.
Dosage & Administration
Dosing by Condition
Moderate scalp psoriasis (adults): apply once daily to dry scalp, leave 15 minutes, then lather and rinse; limit to 4 consecutive weeks and do not exceed 50 mL/week.
Maintenance Dose
Following initial treatment, applications should be spaced out or replaced by an alternative treatment as directed by a physician.
Maximum Dose
50 g (50 ml) per week; maximum treatment duration 4 consecutive weeks
Children's Dosage
Not approved for children under 18 years
Dose Adjustment Notes
No routine hepatic/renal dose adjustment; use the lowest effective amount for the shortest duration, avoid occlusion, and step down (e.g., reduce frequency) once controlled to minimize HPA-axis suppression risk.
How to Take
Apply to DRY scalp once daily: apply a thin layer to affected areas, massage in, leave for 15 minutes (do not cover/occlude), then add water to lather and rinse thoroughly; wash hands after use and avoid contact with eyes/face.
Side Effects
Common Side Effects
Application-site burning/stinging, pruritus, dryness, erythema/irritation, and folliculitis.
Side Effect Frequency
Common: burning/stinging (4.7%), folliculitis, pruritus, dry skin, acne, irritant dermatitis, alopecia, urticaria, skin atrophy, telangiectasia. Systemic: HPA axis suppression, Cushing’s syndrome, hyperglycemia (dose-related).
Safety & Warnings
Contraindications
Hypersensitivity to clobetasol propionate, other corticosteroids, or any excipient; untreated cutaneous/scalp infections; acne vulgaris, rosacea, perioral dermatitis.
Warnings & Precautions
Avoid contact with eyes/mucosa; do not use on face/groin/axillae unless directed; do not use under occlusion; limit duration/area to reduce systemic absorption and HPA suppression; discontinue and treat appropriately if infection develops; stop if significant irritation/sensitization occurs; taper after prolonged use to reduce rebound.
Age Restriction
Not recommended under 18 years.
Special Populations
Pregnancy
Pregnancy Category C: Use only if potential benefit justifies potential risk to fetus
Children
Not approved for children under 18 years
Kidney Impairment
No adjustment needed
Storage & Patient Advice
Stopping the Medicine
Abrupt discontinuation after prolonged or extensive use can cause rebound; taper frequency/strength when stopping after prolonged use (short courses can usually be stopped without taper).
Overdose
Acute topical overdose is unlikely; chronic excessive use can cause HPA axis suppression/hypercortisolism (Cushingoid features, hyperglycemia) and adrenal insufficiency on withdrawal-manage by reducing/discontinuing (often taper if prolonged) and monitoring/supportive care; accidental ingestion warrants medical assessment.
Patient Counseling
Use only on the scalp: apply once daily to dry scalp, leave 15 minutes, then lather and rinse; wash hands after. Avoid eyes/face and do not occlude (no shower cap). Do not use longer than 4 weeks or exceed 50 mL/week without prescriber review. Report irritation, folliculitis/infection, or signs of steroid excess (skin thinning, easy bruising, unusual weight gain/fatigue).
Monitoring Requirements
Reassess response at 4 weeks; monitor for local adverse effects (atrophy, telangiectasia, folliculitis, irritation, secondary infection) and for HPA-axis suppression if high amounts, prolonged use, large surface area, or concomitant steroids are used.
Pharmacology
Duration of Effect
Clinical benefit persists only while used; treatment is limited to a maximum of 4 weeks and relapse may occur after discontinuation.
Half-Life
Unknown / not established for topical clobetasol propionate shampoo (systemic half-life not clinically defined in labeling).
Bioavailability
Percutaneous absorption is variable and generally low with correct use, but increases with inflammation, damaged skin, prolonged use, large area, occlusion, or concomitant steroids.
Product Information
Available Dosage Forms
Shampoo (topical)
Composition per Dose
Each 1 ml shampoo: 0.5 mg clobetasol propionate (0.05%)
Generic Availability
Yes
Skin Condition
Psoriasis
Steroid Potency
Very Potent
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)















